Abdel-Lateef Mohamed A, Darwish Ibrahim A, Gomaa Hassanien, Katamesh Noha S
Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut, 71524, Egypt.
Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh, 11451, Saudi Arabia.
J Fluoresc. 2025 May;35(5):2773-2784. doi: 10.1007/s10895-024-03679-9. Epub 2024 Apr 16.
For the first time, clemastine was estimated in this work utilizing two validated resonance Rayleigh scattering (RRS) and fluorimetric methods. The methods relied on forming an association complex in an acidic medium between eosin Y reagent and clemastine. In the spectrofluorimetric approach, the investigated drug was quantified by quenching the fluorescence-emission intensity of eosin Y at 543.5 nm. The RRS method relied on enhancing the RRS spectrum at 331.8 nm, which is produced when eosin Y interacts with clemastine. Suitable conditions were established for the reaction to achieve maximum sensitivity. The linear values obtained from the spectrofluorimetric approach and the RRS method fall into the ranges of 0.2-1.5 µg mL and 0.25-2.0 µg mL, respectively. It was established that the detection limits for these methods were 0.045 µg mL and 0.059 µg mL, respectively. The developed methodologies yielded acceptable recoveries when used to estimate the quantity of clemastine in its pharmaceutical tablet dosage form. Regarding the use of greener solvents that were chosen, the suggested and reported methods were compared with the help of the Green Solvents Selecting (GSST) tool for assessing hazardous solvents to achieve sustainability. Furthermore, analytical Eco scale and comprehensive assessments of whiteness, blueness, and greenness were carried out utilizing Modified NEMI, ComplexGAPI, and AGREE evaluation tools. Additionally, recently developed tools such as BAGI and RGB 12 were applied to assess the blueness and the whiteness of the suggested methods.
在这项工作中,首次使用两种经过验证的共振瑞利散射(RRS)和荧光法对氯马斯汀进行了测定。这些方法基于在酸性介质中曙红Y试剂与氯马斯汀形成缔合络合物。在荧光光谱法中,通过猝灭曙红Y在543.5 nm处的荧光发射强度来定量研究的药物。RRS方法基于增强在331.8 nm处的RRS光谱,该光谱是曙红Y与氯马斯汀相互作用时产生的。确定了反应的合适条件以实现最大灵敏度。从荧光光谱法和RRS方法获得的线性值分别落在0.2 - 1.5 μg/mL和0.25 - 2.0 μg/mL范围内。已确定这些方法的检测限分别为0.045 μg/mL和0.059 μg/mL。当用于估计其药物片剂剂型中氯马斯汀的含量时,所开发的方法具有可接受的回收率。关于所选择的更环保溶剂的使用,借助绿色溶剂选择(GSST)工具对建议和报道的方法进行了比较,以评估有害溶剂以实现可持续性。此外,利用改进的NEMI、ComplexGAPI和AGREE评估工具对分析生态规模以及白度、蓝度和绿度进行了综合评估。此外,还应用了最近开发的工具如BAGI和RGB 12来评估所建议方法的蓝度和白度。